跳至主要内容
临床试验/NCT06942247
NCT06942247暂停不适用

A Clinical Study to Evaluate the Safety and Efficacy of Biologic Hollow Bone Screws

FengYafei1 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2024年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
暂停
发起方
入组人数
160
试验地点
1
主要终点
Cinical Fracture Healing Rate

研究概览

简要总结

Traditional fracture fixation devices can cause corrosion, allergies, and stress shielding effects. They often require removal after healing, risking secondary damage. Recently, biodegradable materials have gained attention for their effective clinical use in fracture fixation. Absorbable bone nails, for example, eliminate the need for a second surgery, reducing pain and costs while avoiding infection and tissue re-injury. They do not corrode and are invisible on X-rays, allowing for thorough patient examination and better fracture healing assessment.

详细描述

Traditional fracture internal fixation devices implanted in the human body for a long time will cause corrosion, allergy and adverse effects due to stress shielding effect, etc. Due to the non-absorbability of its own materials, it needs to be removed again after fracture healing, which is easy to cause secondary damage to patients. However, in recent years, biodegradable materials have attracted the attention of scholars. The fracture fixation made of biodegradable biomaterials has achieved better internal fixation effect in clinic. For example, the implantation of absorbable bone nails can enable patients to avoid a second surgery, reduce the pain and economic burden of patients, while avoiding the problems of infection and tissue re-injury caused by the second surgery. In addition, absorbable bone nails have no metal corrosion effect and are not visible under the X-ray line, which is conducive to comprehensive examination of the patient and further understanding of the fracture healing. Common biodegradable materials are polymer materials (such as polylactic acid), ceramic materials (such as calcium phosphate) and metal materials. Among them, the strength of polymer materials is lower, and the toughness of ceramic materials is poorer, while the bone nails made of natural silk protein are biocompatible, non-toxic, no irritant, no side-effective, no antigenic and no carcinogenic to tissues. It can be completely degraded into amino acids and peptides in the body, participate in human metabolism, and eventually be excreted from the body. Silk was first used as a surgical suture, which can be gradually absorbed and degraded by the body after wound healing, which protected patients from the pain of removing stitches. Animal experiments have shown that the use of silk protein gel and commonly used ethyl lactate to repair rabbit thigh bone injuries, with the number, thickness and gap of bone trabeculae as evaluation indexes, the result showed that the use of silk protein gel was more conducive to the repair of rabbit thigh bone injury, and was also closer to the regeneration of human bone. In addition, the silk was able to maintain 50% tension two months after implantation in the animals.

Therefore, the purpose of this clinical trial study was to evaluate the safety and effectiveness of biologic hollow bone screws for the fixation of fractures in the knee joint and ankle joint. Researchers can use the above results to provide better treatment for patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

盲法说明

The researchers can visually distinguish the experiment products and the control products, so the researchers cannot be blinded and the participants were blinded.

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Aged 18-75 years old (inclusive), both sexes;
  • •Patients with knee and ankle fractures requiring internal fixation confirmed by imaging examination;
  • •Voluntary participation in the clinical trial and signing of the informed consent.

排除标准

  • •The following conditions exist at the fracture site: infection, osteofascial compartment syndrome, osteitis, pathological fracture, open fracture, severe tissue or vascular and nerve injury, or insufficient bone mass of the affected limb affecting screw implantation, etc.
  • •Abnormal liver and kidney function with clinical significance (ALT, AST 2 times the upper limit of normal value and Cr 2 times the upper limit of normal value);
  • •Abnormal coagulation function with clinical significance (APTT > 2 times the upper limit of normal value);
  • •Patients with difficult-to-control diabetes (any blood glucose > 11.1mmol/L or glycosylated hemoglobin > 9%);
  • •Past allergies to silk protein materials;
  • •Mental illness;
  • •Patients who cannot guarantee to quit smoking during the fracture healing period;
  • •Pregnant or lactating women or women of childbearing age who plan to get pregnant within 6 months;
  • •Those who have participated in other pre-clinical trials within 1 month before the trial;
  • •Those who are considered inappropriate to participate in the clinical trial.

研究组 & 干预措施

Inion Freedom Screws

Active Comparator

Patients were treated with screws developed by Inion Oy, Finland for the fixation of fractures in the knee and ankle joints.

干预措施: Active Comparator: Fracture Fixation (Inion Freedom Screws) (Device)

Biologic Hollow Bone Screws

Experimental

Patients were treated with screws developed by Jiangxi Sike Biotechnology, China for the fixation of fractures in the knee and ankle joints.

干预措施: Experimental: Fracture Fixation (Biological Hollow Bone Screws) (Device)

结局指标

主要结局

Cinical Fracture Healing Rate

时间窗: 24 weeks after surgery+4 weeks

1. No local tenderness or longitudinal percussion pain, no local abnormal activity; 2. X-rays show a continuous bone scab or trabeculae crossing the fracture line at the fracture site and the fracture line has been blurred. If both of these are met, the fracture is considered healed, and vice versa. 3. Healing rate = (Healing cases / Total cases) ×100%

次要结局

  • Cinical Fracture Healing Rate(72 weeks after surgery± 4 weeks)
  • Visual Analogue Scale (VAS)(72 weeks after surgery± 4 weeks)
  • The American Knee Society (AKS) Clinical Rating System(72 weeks after surgery± 4 weeks)
  • Mazur Ankle Joint Functional Evaluation(72 weeks after surgery± 4 weeks)
  • Cinical Fracture Healing Rate(12 weeks after surgery±1 week)
  • Cinical Fracture Healing Rate(48 weeks after surgery± 4 weeks)
  • Visual Analogue Scale (VAS)(During the screening period)
  • Visual Analogue Scale (VAS)(Within 1 week after surgery (≤7 days))
  • Visual Analogue Scale (VAS)(6 weeks after surgery±1 week)
  • Visual Analogue Scale (VAS)(12 weeks after surgery±1 week)
  • Visual Analogue Scale (VAS)(24 weeks after surgery±4 weeks)
  • Visual Analogue Scale (VAS)(48 weeks after surgery±4 weeks)
  • The American Knee Society (AKS) Clinical Rating System(6 weeks after surgery±1 week)
  • The American Knee Society (AKS) Clinical Rating System(12 weeks after surgery±1 week)
  • The American Knee Society (AKS) Clinical Rating System(24 weeks after surgery±4 weeks)
  • The American Knee Society (AKS) Clinical Rating System(48 weeks after surgery±4 weeks)
  • Mazur Ankle Joint Functional Evaluation(6 weeks after surgery±1 week)
  • Mazur Ankle Joint Functional Evaluation(12 weeks after surgery±1 week)
  • Mazur Ankle Joint Functional Evaluation(24 weeks after surgery±4 weeks)
  • Mazur Ankle Joint Functional Evaluation(48 weeks after surgery±4 weeks)

研究者

发起方
FengYafei
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

FengYafei

Associate professor

Xijing Hospital

研究点 (1)

Loading locations...

相似试验